Immunosequencing: applications of immune repertoire deep sequencing

H Robins - Current opinion in immunology, 2013 - Elsevier
Highlights•New technology to profile the adaptive immune system with high-throughput
sequencing of adaptive immune receptors.•Ability to follow the dynamics of an adaptive …

Getting personal with neoantigen-based therapeutic cancer vaccines

N Hacohen, EF Fritsch, TA Carter, ES Lander… - Cancer immunology …, 2013 - AACR
Despite years of preclinical efforts and hundreds of clinical studies, therapeutic cancer
vaccines with the routine ability to limit or eliminate tumor growth in humans have been …

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients

PY Yew, H Alachkar, R Yamaguchi, K Kiyotani… - Bone marrow …, 2015 - nature.com
Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment
options for patients with hematologic malignancies. Although GVHD mediated by the donor's …

60 years young: the evolving role of allogeneic hematopoietic stem cell transplantation in cancer immunotherapy

N Cieri, K Maurer, CJ Wu - Cancer research, 2021 - AACR
The year 2020 marked the 30th anniversary of the Nobel Prize in Medicine awarded to E.
Donnall Thomas for the development of allogeneic hematopoietic stem cell transplantation …

New challenges, new opportunities: Next generation sequencing and its place in the advancement of HLA typing

V Bravo-Egana, H Sanders, N Chitnis - Human Immunology, 2021 - Elsevier
Abstract The Human Leukocyte Antigen (HLA) system has a critical role in
immunorecognition, transplantation, and disease association. Early typing techniques …

Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies

G Lucchini, MA Perales, P Veys - Cytotherapy, 2015 - Elsevier
Umbilical cord blood (UCB) is now widely used as an alternative hematopoietic stem cell
source for patients lacking closely matched related or unrelated adult donors. UCB …

Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection

H Alachkar, M Mutonga, T Kato, S Kalluri, Y Kakuta… - BMC nephrology, 2016 - Springer
Background T-cell-mediated rejection (TCMR) remains a major cause of kidney allograft
failure. The characterization of T-cell repertoire in different immunological disorders has …

GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses

L Sellner, M Brüggemann, M Schlitt, H Knecht… - Bone marrow …, 2017 - nature.com
Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-
prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is …

Diagnostic applications of next generation sequencing in immunogenetics and molecular oncology

B Grumbt, SH Eck, T Hinrichsen, K Hirv - Transfusion Medicine and …, 2013 - karger.com
With the introduction of the next generation sequencing (NGS) technologies, remarkable
new diagnostic applications have been established in daily routine. Implementation of NGS …

Impact of next generation sequencing results on clinical management in patients with hematological disorders

BJ Patel, SV Barot, Y Xie, JR Cook… - Leukemia & …, 2021 - Taylor & Francis
Application of next generation sequencing (NGS) has shed light on the molecular
heterogeneity of hematological malignancies. NGS panels targeting recurrent mutations …